Phosphoserine aminotransferase 1 pseudogene 2 (PSAT1P2)

Phosphoserine aminotransferase 1 pseudogene 2 (PSAT1P2) is a genomic sequence similar to the gene encoding phosphoserine aminotransferase 1 (PSAT1), but does not produce a functional protein. Pseudogenes such as PSAT1P2 may arise via gene duplication or retrotransposition. There is no evidence that PSAT1P2 is expressed or functional, nor is it considered a direct target for therapeutic intervention. Existing scientific literature and genetic resources focus on the parent gene, PSAT1, which encodes a pyridoxal-phosphate-dependent transaminase involved in serine biosynthesis and associated with multiple human diseases, but do not indicate a functional or disease-associated role for PSAT1P2. The term “psuedogene” refers to a DNA sequence similar to a gene but generally nonfunctional due to disabling mutations. PSAT1, not PSAT1P2, is the enzyme implicated in metabolism, cancer biology, and metabolic disorders. PSAT1P2 itself has no known activity or biological function and is not referenced as a therapeutic or pharmacological target in current biomedical literature. Multiple PSAT1 pseudogenes exist in the human genome, but none are annotated as protein-coding or functional. The query refers to a pseudogene (PSAT1P2), not a canonical protein target. The correct target, if relevant for therapeutic context, would be phosphoserine aminotransferase 1 (PSAT1); PSAT1P2 itself is not considered a therapeutic target and has no established role in disease or drug interaction.

Other names

PSAT1P2phosphoserine aminotransferase pseudogene 2phosphoserine aminotransferase 1 pseudogene 2